| Literature DB >> 34325119 |
Isabel Cristina Guerra-Gomes1, Bruna Macêdo Gois1, Rephany Fonseca Peixoto1, Pedro Henrique de Sousa Palmeira1, Cínthia Nóbrega de Sousa Dias1, Bárbara Guimarães Csordas1, Josélio Maria Galvão Araújo2, Robson Cavalcante Veras3, Isac Almeida de Medeiros3, Fátima de Lourdes Assunção Araújo de Azevedo3, Rosemary Jane Boyton4, Daniel Martin Altmann5, Tatjana Souza Lima Keesen6.
Abstract
Zika virus (ZIKV), alongside Dengue virus (DENV), Chikungunya virus (CHIKV), and Yellow Fever Virus (YFV) are prevalent arboviruses in the Americas. Each of these infections is associated with the development of associated disease immunopathology. Immunopathological processes are an outcome of counter-balancing impacts between effector and regulatory immune mechanisms. In this context, regulatory T cells (Tregs) are key in modulating the immune response and, therefore, in tissue damage control. However, to date, Treg phenotypes and mechanisms during acute infection of the ZIKV in humans have not been fully investigated. The main aim of this work was to characterize Tregs and their immunological profile related to cytokine production and molecules that are capable of controlling the exacerbated inflammatory profile in acute Zika infected patients. Using whole blood analyses of infected patients, an ex vivo phenotypical characterization of Tregs, circulating during acute Zika virus infection, was conducted by flow cytometry. We found that though there are no differences in absolute Treg frequency between infected and healthy control groups. However, pro-inflammatory cytokine up-regulation such as IFN-γ and LAP was observed in the acute disease. Furthermore, acute ZIKV patients expressed increased levels of CD39/CD73, perforin/granzyme B, PD-1, and CTLA-4, all markers involved in mechanisms used by Tregs to attempt to control strong inflammatory responses. Thus, the data indicates a potential contribution of Tregs during the inflammatory ZIKV infection response.Entities:
Keywords: Blood; Human; Infection; T cells; Viral
Mesh:
Substances:
Year: 2021 PMID: 34325119 PMCID: PMC8405058 DOI: 10.1016/j.cyto.2021.155651
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.926